Research ArticleBehavioral Pharmacology
Prolonged Monoacylglycerol Lipase Blockade Causes Equivalent Cannabinoid Receptor Type 1 Receptor–Mediated Adaptations in Fatty Acid Amide Hydrolase Wild-Type and Knockout Mice
Joel E. Schlosburg, Steven G. Kinsey, Bogna Ignatowska-Jankowska, Divya Ramesh, Rehab A. Abdullah, Qing Tao, Lamont Booker, Jonathan Z. Long, Dana E. Selley, Benjamin F. Cravatt and Aron H. Lichtman
Journal of Pharmacology and Experimental Therapeutics August 2014, 350 (2) 196-204; DOI: https://doi.org/10.1124/jpet.114.212753
Joel E. Schlosburg
Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, Virginia (J.E.S., B.I.-J., D.R., R.A.A., Q.T., L.B., D.E.S., A.H.L.); Department of Psychology, West Virginia University, Morgantown, West Virginia (S.G.K.); and The Skaggs Institute for Chemical Biology and Department of Chemical Physiology (J.Z.L., B.F.C.), and Committee on the Neurobiology of Addictive Disorders (J.E.S.), The Scripps Research Institute, La Jolla, California
Steven G. Kinsey
Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, Virginia (J.E.S., B.I.-J., D.R., R.A.A., Q.T., L.B., D.E.S., A.H.L.); Department of Psychology, West Virginia University, Morgantown, West Virginia (S.G.K.); and The Skaggs Institute for Chemical Biology and Department of Chemical Physiology (J.Z.L., B.F.C.), and Committee on the Neurobiology of Addictive Disorders (J.E.S.), The Scripps Research Institute, La Jolla, California
Bogna Ignatowska-Jankowska
Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, Virginia (J.E.S., B.I.-J., D.R., R.A.A., Q.T., L.B., D.E.S., A.H.L.); Department of Psychology, West Virginia University, Morgantown, West Virginia (S.G.K.); and The Skaggs Institute for Chemical Biology and Department of Chemical Physiology (J.Z.L., B.F.C.), and Committee on the Neurobiology of Addictive Disorders (J.E.S.), The Scripps Research Institute, La Jolla, California
Divya Ramesh
Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, Virginia (J.E.S., B.I.-J., D.R., R.A.A., Q.T., L.B., D.E.S., A.H.L.); Department of Psychology, West Virginia University, Morgantown, West Virginia (S.G.K.); and The Skaggs Institute for Chemical Biology and Department of Chemical Physiology (J.Z.L., B.F.C.), and Committee on the Neurobiology of Addictive Disorders (J.E.S.), The Scripps Research Institute, La Jolla, California
Rehab A. Abdullah
Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, Virginia (J.E.S., B.I.-J., D.R., R.A.A., Q.T., L.B., D.E.S., A.H.L.); Department of Psychology, West Virginia University, Morgantown, West Virginia (S.G.K.); and The Skaggs Institute for Chemical Biology and Department of Chemical Physiology (J.Z.L., B.F.C.), and Committee on the Neurobiology of Addictive Disorders (J.E.S.), The Scripps Research Institute, La Jolla, California
Qing Tao
Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, Virginia (J.E.S., B.I.-J., D.R., R.A.A., Q.T., L.B., D.E.S., A.H.L.); Department of Psychology, West Virginia University, Morgantown, West Virginia (S.G.K.); and The Skaggs Institute for Chemical Biology and Department of Chemical Physiology (J.Z.L., B.F.C.), and Committee on the Neurobiology of Addictive Disorders (J.E.S.), The Scripps Research Institute, La Jolla, California
Lamont Booker
Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, Virginia (J.E.S., B.I.-J., D.R., R.A.A., Q.T., L.B., D.E.S., A.H.L.); Department of Psychology, West Virginia University, Morgantown, West Virginia (S.G.K.); and The Skaggs Institute for Chemical Biology and Department of Chemical Physiology (J.Z.L., B.F.C.), and Committee on the Neurobiology of Addictive Disorders (J.E.S.), The Scripps Research Institute, La Jolla, California
Jonathan Z. Long
Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, Virginia (J.E.S., B.I.-J., D.R., R.A.A., Q.T., L.B., D.E.S., A.H.L.); Department of Psychology, West Virginia University, Morgantown, West Virginia (S.G.K.); and The Skaggs Institute for Chemical Biology and Department of Chemical Physiology (J.Z.L., B.F.C.), and Committee on the Neurobiology of Addictive Disorders (J.E.S.), The Scripps Research Institute, La Jolla, California
Dana E. Selley
Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, Virginia (J.E.S., B.I.-J., D.R., R.A.A., Q.T., L.B., D.E.S., A.H.L.); Department of Psychology, West Virginia University, Morgantown, West Virginia (S.G.K.); and The Skaggs Institute for Chemical Biology and Department of Chemical Physiology (J.Z.L., B.F.C.), and Committee on the Neurobiology of Addictive Disorders (J.E.S.), The Scripps Research Institute, La Jolla, California
Benjamin F. Cravatt
Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, Virginia (J.E.S., B.I.-J., D.R., R.A.A., Q.T., L.B., D.E.S., A.H.L.); Department of Psychology, West Virginia University, Morgantown, West Virginia (S.G.K.); and The Skaggs Institute for Chemical Biology and Department of Chemical Physiology (J.Z.L., B.F.C.), and Committee on the Neurobiology of Addictive Disorders (J.E.S.), The Scripps Research Institute, La Jolla, California
Aron H. Lichtman
Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, Virginia (J.E.S., B.I.-J., D.R., R.A.A., Q.T., L.B., D.E.S., A.H.L.); Department of Psychology, West Virginia University, Morgantown, West Virginia (S.G.K.); and The Skaggs Institute for Chemical Biology and Department of Chemical Physiology (J.Z.L., B.F.C.), and Committee on the Neurobiology of Addictive Disorders (J.E.S.), The Scripps Research Institute, La Jolla, California
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleBehavioral Pharmacology
Prolonged Inhibition of Endocannabinoid Catabolic Enzymes
Joel E. Schlosburg, Steven G. Kinsey, Bogna Ignatowska-Jankowska, Divya Ramesh, Rehab A. Abdullah, Qing Tao, Lamont Booker, Jonathan Z. Long, Dana E. Selley, Benjamin F. Cravatt and Aron H. Lichtman
Journal of Pharmacology and Experimental Therapeutics August 1, 2014, 350 (2) 196-204; DOI: https://doi.org/10.1124/jpet.114.212753
Research ArticleBehavioral Pharmacology
Prolonged Inhibition of Endocannabinoid Catabolic Enzymes
Joel E. Schlosburg, Steven G. Kinsey, Bogna Ignatowska-Jankowska, Divya Ramesh, Rehab A. Abdullah, Qing Tao, Lamont Booker, Jonathan Z. Long, Dana E. Selley, Benjamin F. Cravatt and Aron H. Lichtman
Journal of Pharmacology and Experimental Therapeutics August 1, 2014, 350 (2) 196-204; DOI: https://doi.org/10.1124/jpet.114.212753
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement